Cancer

Do you or someone you know well been affected by non-small cell lung cancer harbouring the KRAS G12C mutation? Your input is needed on a protocol considering KRAS G12C inhibitors versus chemotherapy for people with [condition].

Skills / interests: Patient and public input

I am looking for a consumer who would be willing to provide feedback for a Cochrane protocol, “KRAS G12C inhibitors versus chemotherapy in second line and beyond in people with advanced or metastatic non-small cell lung cancer (NSCLC) harbouring the KRAS G12C mutation”. Cochrane considers a consumer to be a person with experience of the condition (in this case, metastatic non-small cell lung cancer (NSCLC) harbouring the KRAS G12C mutation), either as a patient or as a carer/family member of a patient. 

A protocol is a plan for a systematic review. Consumer input at protocol stage is integral to ensure that the completed systematic review will be helpful to patients and carers with healthcare decision making. For consumer peer review, you will be asked to complete a short form with your feedback. Our aim is for this to be a manageable task, that does not overburden consumer reviewers.   

 

Thank you in advance for considering! 

Ideal applicant

a person with experience of the condition (in this case, metastatic non-small cell lung cancer (NSCLC) harbouring the KRAS G12C mutation)

Think you've got what it takes to get the job done for Lisa?

Log in
to respond

Questions & comments